The immunosuppressant Rituximab may ease arthritis — an inflammation of the joints — in patients with long-standing systemic sclerosis (SSc), a small Turkish study found. Moreover, in some patients, skin and lung symptoms either remained stable or eased, the researchers also observed. Read more here.
Comments are closed.
|
AuthorScleroderma Queensland Support Group Archives
December 2024
Categories
All
|